Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,971 | 4,617 | 6,359 | 35,968 | 29,474 |
| Marketable Securities | N/A | N/A | N/A | 15 | 8,530 |
| Receivables | 79 | 2,539 | 2,591 | 34,521 | 31,677 |
| Inventories | N/A | 3,651 | 4,389 | 11,009 | 14,810 |
| TOTAL | $6,528 | $11,911 | $16,140 | $85,900 | $89,152 |
| Non-Current Assets | |||||
| PPE Net | 49 | 135 | 193 | 502 | 572 |
| Investments And Advances | 12,050 | 0 | 0 | 0 | 0 |
| Intangibles | 5,291 | 5,547 | 5,578 | 65,626 | 71,644 |
| Other Non-Current Assets | 1,427 | 450 | 1,136 | 6,842 | 19,820 |
| TOTAL | $18,817 | $6,132 | $6,907 | $72,970 | $92,036 |
| Total Assets | $25,345 | $18,043 | $23,047 | $158,870 | $181,188 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 115,216 | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 3,278 | 15,387 | 28,245 |
| Accrued Expenses | N/A | N/A | 4,592 | 17,949 | 20,896 |
| Other current liabilities | N/A | N/A | 11,395 | 47,870 | 30,711 |
| TOTAL | $19,221 | $22,223 | $19,983 | $197,454 | $81,470 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 83,620 |
| Other Non-Current Liabilities | 1,856 | 503 | 995 | 9,816 | 7,223 |
| TOTAL | $1,856 | $503 | $995 | $9,816 | $90,843 |
| Total Liabilities | $21,077 | $22,726 | $20,978 | $207,270 | $172,313 |
| Shareholders' Equity | |||||
| Common Shares | 147,641 | 35,036 | 21,441 | 2,835 | 1,495 |
| Retained earnings | -413,755 | -414,801 | -407,735 | -433,860 | -367,866 |
| TOTAL | $4,268 | $-4,683 | $2,069 | $-48,400 | $8,875 |
| Total Liabilities And Equity | $25,345 | $18,043 | $23,047 | $158,870 | $181,188 |